Abstract
Increased vancomycin minimum inhibitory concentration (MIC) levels in Staphylococcus aureus and their association with vancomycin treatment failure are well-known problems. Few studies have recognized progressive increases in glycopeptide MIC levels for S. aureus strains in recent years. This study determined glycopeptide and daptomycin susceptibility among methicillin resistant S. aureus (MRSA) strains. A total of 776 clinical isolates of MRSA recovered from 2009 to 2012 were studied for glycopeptide and daptomycin susceptibility using the E-test method. The vancomycin MIC geometric mean (GM) of the MRSA isolates was 0.923, 0.944, 1.134 and 1.294 mg/L in the years 2009, 2010, 2011 and 2012, respectively, and the trend significantly increased over the years (P < 0.0001). Similarly, the teicoplanin MIC GM was 1.47, 1.49, 1.8 and 2.04 mg/L in the years from 2009 to 2012, respectively (P < 0.0001). MIC shifts were not found for daptomycin (P > 0.232). A significant increase in the MIC for glycopeptides was observed among the clinical MRSA isolates at our center over a 4-year period. However, the daptomycin MIC did not increase in the observed MRSA isolates.
References
Jan 1, 1993·The Journal of Antimicrobial Chemotherapy·R L WhiteV E Del Bene
Mar 2, 2002·The Lancet Infectious Diseases·K Hiramatsu
Aug 27, 2002·The Journal of Infectious Diseases·Farid M HussainRobert S Daum
Sep 8, 2006·Journal of Clinical Microbiology·Guiqing WangDavid A Bruckner
Apr 25, 2007·Antimicrobial Agents and Chemotherapy·Pamela A MoiseJerome J Schentag
Jul 12, 2007·The Journal of Antimicrobial Chemotherapy·Gregory SteinkrausLawrence Friedrich
Sep 25, 2007·International Journal of Antimicrobial Agents·Peter C Appelbaum
Nov 28, 2007·Antimicrobial Agents and Chemotherapy·Robert L Holmes, James H Jorgensen
May 20, 2008·International Journal of Antimicrobial Agents·Ian M Gould
Jan 11, 2011·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Catherine LiuHenry F Chambers
Jan 22, 2011·Intensive Care Medicine·Eun Young ChoiSang-Bum Hong
Nov 9, 2011·Antimicrobial Agents and Chemotherapy·Susan L FinkThomas S Murray
Jan 25, 2012·Bulletin of the World Health Organization·Tia Palermo, Amber Peterman
Aug 14, 2012·FEMS Yeast Research·Sonia U PuriscoMarcia S C Melhem
Oct 24, 2012·International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases·Jesse T Jacob, Carlos A DiazGranados
Aug 28, 2013·Antimicrobial Agents and Chemotherapy·So-Youn ParkMi-Na Kim